DrugInfoSys

Carboplatin

Drug #133

Carboplatin is an alkylating anticancerous drug. Carboplatin is a platinium co-ordination compound having the same mechanism of action as cisplatin. Carboplatin is effective in the treatment of ovarian cancer, non-small cell lung cancer, germ cell , head and neck, and oesophageal cancers. Carboplatin is used alone or in combination with different anti-cancerous drugs to obtain best therapeutic effects and to reduce side effects or toxicities.

Primary Characteristics

It is of Synthetic origin and belongs to Cyclobutane Platinum.

It belongs to Cross Linkage (DNA acting) pharmacological group on the basis of mechanism of action and also classified in Antineoplastic Agent, Alkylating Agent pharmacological group.

Molecular Weight: 371.3 · Solubility in Water: < 1 in 10 · Solubility in Alcohol: < 1 in 1000 · Non-proprietary name: Carboplatin.

Molecular structure of Carboplatin

Pharmacokinetics

Distribution: Carboplatin has a volume of distribution is 0.17l/kg. plasma protein binding is 24%.

Elimination: plasma half-life is 1.5 hr, renal excretion is entire.

Advertisement

Indications

Carboplatin is primarily indicated in conditions like Advanced ovarian cancer, Head and neck cancer, Lung cancer, Ovarian cancer, Small cell lung cancer.

Carboplatin is also indicated for secondary conditions like Colorectal cancer, Gastric cancer, Malignant lymphoma, Non-small cell lung carcinoma.

Contraindications

Carboplatin is contraindicated in conditions like Allergy.

Dosage

Carboplatin's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
400 mg/sq.meter400 mg/sq.meterIV Inf Once over 15-60 Minutes
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Moderate1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Carboplatin in overdosage may give rise to further complications which include Nephrotoxicity , Gi bleeding , Hepatotoxicity , Ototoxicity , Blood dyscrasias , Peripheral neuropathy .

Carboplatin produces potentially life-threatening effects which include Thrombocytopenia , Myelosuppression . Careful monitoring is needed with proper medical management.

Carboplatin is known to cause more or less tolerable side effects which are usually transient. These include Alopecia, Anorexia , Arthralgia, Asthenia , Blurred vision, Diarrhea, Malaise, Myalgia, Pain at injection site, Rashes , Vomiting .

Warnings / Precautions

Carboplatin should be used with caution in patients with pre-existing blood disorders or bone marrow disease, kidney disease or any allergy. Carboplatin is classified as pregnancy category D and should be avoided during pregnancy or lactation.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Carboplatin should be stored Inj (reconstituted soln). IV inf .

Drug Classification

  1. 1.8.2Cytotoxic (anti-neoplastic) drugs

Manufacturers

Manufacturers of Carboplatin in Pakistan: